ROBERT ROSEN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

HERON THERAPEUTICS, INC. /DE/

Filing Date Source Excerpt
2013-08-26 Robert Rosen, President, Director, includes 52,813 shares of common stock and 2,528,256 shares underlying stock options exercisable within 60 days of July 31, 2013.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22